Novel insights into the biomarkers and therapies for primary central nervous system lymphoma

Primary central nervous system lymphoma (PCNSL) is a rare and highly aggressive extranodal type of non-Hodgkin lymphoma. After the introduction and widespread use of high-dose-methotrexate (HD-MTX)-based polychemotherapy, treatment responses of PCNSL have been improved. However, long-term prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Yujia, Zhou, Xiangxiang, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087239/
https://www.ncbi.nlm.nih.gov/pubmed/35558005
http://dx.doi.org/10.1177/17588359221093745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087239/
https://www.ncbi.nlm.nih.gov/pubmed/35558005
http://dx.doi.org/10.1177/17588359221093745

Ejemplares similares